medical device investing Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
medical device investing Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
medical device investing Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
medical device investing Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
medical device investing Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
medical device investing Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
Homerun Resources Inc. Announces Closing of Initial Tranche of Convertible Security Financing with the Lind Partners Under Engagements with Benchmark/StoneX
Premier American Uranium Identifies Multiple Mineralized Uranium Trends in Ongoing Drilling at Kaycee, Wyoming
